Reported about 23 hours ago
Billionaire investors are heavily investing in the dividend stock AbbVie, which has shown potential with its successful drugs and strong dividend history. While AbbVie has raised its dividends significantly since 2013 and offers a good yield, there are risks, including declining sales from major products and competition from cheaper alternatives. Analysts recommend cautious consideration before investing, especially as AbbVie didn't make the list of the top stocks suggested by The Motley Fool's advisor team.
Source: YAHOO